|
⚲
|
| Keyboard |
| Wilson Marc
✚
|
|
|---|---|
| CIK # | 0001702265 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001702265] | |
| 4 | [0001702265] | |
| 5 | [0001702265] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Crinetics Pharmaceuticals Inc | |
| Wilson Marc | |
| K2 Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-11-20 | Other | 473 | $14.98 | 7,086 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-09-26 | Option exercise | 25,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-09-26 | Sell | 25,000 | $51.11 | 1,277,750 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-09-26 | Option exercise | 25,000 | $15.29 | 382,250 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-25 | Option exercise | 19,056 | $9.28 | 176,840 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-25 | Sell | 19,056 | $53.88 | 1,026,737 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-25 | Option exercise | 19,056 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Option exercise | 25,000 | $20.02 | 500,500 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-07-15 | Sell | 25,000 | $55.00 | 1,375,000 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-07-15 | Option exercise | 25,000 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-06-28 | Sell | 32,129 | $43.61 | 1,401,146 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-06-28 | Option exercise | 32,129 | $9.28 | 298,157 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock option (Right to Buy) · derivative
|
2024-06-28 | Option exercise | 32,129 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-19 | Sell | 6,942 | $42.91 | 297,881 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-18 | Tax withheld | 3,983 | $38.14 | 151,912 |
|
Crinetics Pharmaceuticals Inc CRNX
Stock Option (right to buy) · derivative
|
2024-03-04 | Grant | 95,500 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-03-04 | Grant | 25,500 | $0.00 | |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-01-02 | Option exercise | 10,000 | $9.28 | 92,800 |
|
Crinetics Pharmaceuticals Inc CRNX
Common Stock
|
2024-01-02 | Sell | 10,000 | $35.47 | 354,700 |
|
Crinetics Pharmaceuticals Inc CRNX
Non-qualified stock option (Right to Buy) · derivative
|
2024-01-02 | Option exercise | 10,000 | $0.00 | |
| showing 20 of 47 most recent transactions | |||||